Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirturo (bedaquiline) in Japanese Patients With Pulmonary MDR-TB
NCT02365623Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bedaquiline in Tuberculosis (TB), sponsored by Janssen Pharmaceutical. Started Feb 2015; status: completed.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02365623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365623.